89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 154 filers reported holding 89BIO INC in Q4 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,469,257 | -44.4% | 2,180,931 | -19.2% | 0.21% | -22.2% |
| Q1 2024 | $31,421,831 | +4.0% | 2,699,470 | -0.2% | 0.27% | +3.9% |
| Q4 2023 | $30,205,936 | +62.3% | 2,704,202 | +124.3% | 0.26% | +124.6% |
| Q3 2023 | $18,615,051 | +35.1% | 1,205,638 | +65.8% | 0.11% | +48.1% |
| Q2 2023 | $13,776,764 | +107.1% | 727,006 | +66.4% | 0.08% | +71.1% |
| Q1 2023 | $6,653,759 | +179.4% | 436,885 | +133.5% | 0.04% | +309.1% |
| Q4 2022 | $2,381,783 | +119.9% | 187,100 | 0.0% | 0.01% | +83.3% |
| Q3 2022 | $1,083,000 | +79.9% | 187,100 | 0.0% | 0.01% | -33.3% |
| Q2 2022 | $602,000 | – | 187,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |